COVID-19 vaccine could be ready in time for US electionsHealth officials in the US have been told to prepare for a COVID-19 vaccine to be ready by Share XCOVID-19 vaccine could be ready in time for US electionshttps://pharmaphorum.com/news/covid-19-vaccine-could-be-ready-in-time-for-us-elections/
Ionis deal delivers for GSK as HBV drug hits the mark in phase 2An antisense drug developed by GlaxoSmithKline has been shown to suppress the hepatitis B virus (HBV) in a Share XIonis deal delivers for GSK as HBV drug hits the mark in phase 2https://pharmaphorum.com/news/ionis-deal-delivers-for-gsk-as-hbv-drug-hits-the-mark-in-phase-2/
Novo-backed $61m fundraising helps F2G prep for antifungal launchAnglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening Share XNovo-backed $61m fundraising helps F2G prep for antifungal launchhttps://pharmaphorum.com/news/novo-backed-61m-fundraising-helps-f2g-prep-for-antifungal-launch/
UK firms plan early-warning detector for COVID-19 in wastewaterSewage monitoring is being trialled as a way to spot new outbreaks of coronavirus, and three UK companies Share XUK firms plan early-warning detector for COVID-19 in wastewaterhttps://pharmaphorum.com/news/uk-firms-plan-early-warning-detector-for-covid-19-in-wastewater/
Gilead starts trials of inhaled remdesivir for earlier-stage COVID-19The first healthy volunteers have started to receive doses of Gilead’s inhaled formulation of remdesivir, which it hopes Share XGilead starts trials of inhaled remdesivir for earlier-stage COVID-19https://pharmaphorum.com/news/gilead-starts-trials-of-inhaled-remdesivir-for-earlier-stage-covid-19/
US snaps up first supplies of Regeneron’s COVID-19 antibodyHard on the heels of Regeneron moving its COVID-19 antibody cocktail into late-stage testing, the US government has Share XUS snaps up first supplies of Regeneron’s COVID-19 antibodyhttps://pharmaphorum.com/news/us-snaps-up-first-supplies-of-regenerons-covid-19-antibody/
ViiV gets FDA nod for Rukobia drug for older HIV patientsThe FDA has approved Rukobia, a first-in-class drug from ViiV Healthcare intended for older people with HIV, who Share XViiV gets FDA nod for Rukobia drug for older HIV patientshttps://pharmaphorum.com/news/viiv-gets-fda-nod-for-rukobia-drug-for-older-hiv-patients/
US advisors add steroids to COVID-19 drug recommendationsThe Infectious Diseases Society of America (IDSA) says generic steroids should be used to treat patients hospitalised with Share XUS advisors add steroids to COVID-19 drug recommendationshttps://pharmaphorum.com/news/us-advisors-add-steroids-to-covid-19-drug-recommendations/
Ferring’s gut microbiome drug clears phase 3 trial in C. diffFerring Pharma has reported what it says is the first positive phase 3 trial of a microbiome therapy Share XFerring’s gut microbiome drug clears phase 3 trial in C. diffhttps://pharmaphorum.com/news/ferrings-gut-microbiome-drug-clears-phase-3-trial-in-c-diff/
